Related Experiment Video
Updated: Sep 12, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
9-Year Follow-Up of a Pediatric LQTS Patient With a Subcutaneous ICD: Considerations for ILR Monitoring
Yuya Nakamura1, Yoshikazu Suzuki1, Haruka Miyazaki1
1Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Background:
Long QT syndrome (LQTS) is a congenital arrhythmic disorder associated with sudden cardiac death. In patients at low to intermediate risk, implantable loop recorders (ILRs) are sometimes used for arrhythmic surveillance. Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are considered in children, but long-term follow-up data remain limited.
Case Summary:
A 9-year-old patient with genetically confirmed LQT1 initially received an ILR. After a syncopal event, an S-ICD was implanted using a 2-incision intermuscular and C-curve technique to accommodate anticipated growth. The S-ICD recorded a short episode of torsades de pointes (TdP) that was not detected by the ILR. After reprogramming with more permissive settings, both devices successfully detected subsequent TdP episodes. Over 9 years of follow-up, the S-ICD maintained stable sensing and function.
Discussion:
This case illustrates the diagnostic limitations of ILRs and demonstrates the feasibility and durability of growth-conscious S-ICD implantation in pediatric patients with LQTS.
More Related Videos
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation III: Medical Management